Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response
An Exploratory Study of Efficacy and Tolerance on Selected Natural Extracts, With the Potential of Reducing Post Prandial Blood Glucose Response, in Healthy Indian Adult Subjects
Sponsor: Lambda Therapeutic Research Ltd.
A NA clinical study on Blood Glucose, this trial is completed. The trial is conducted by Lambda Therapeutic Research Ltd. and has accumulated 4 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lambda Therapeutic Research Ltd.
- Unilever R&D
For direct contact, visit the study record on ClinicalTrials.gov .